Public recall detail

Pfizer Champix Product Recall (2021-06-08)

medium
Recall Safety notice
Quick summary

Quick summary: Pfizer Champix Product Recall (2021-06-08) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Pfizer Champix Product Recall (2021-06-08) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionA. Champix 0.5 mg tablets DIN, NPN, DIN-HIM DIN 02291177 Dosage form Tablet Strength Varenicline tartrate 0.5 mg Lot or serial number ED7397 Companies Recalling Firm Pfizer Canada ULC 17300 Trans-Canada Highway Kirkland H9J 2M5 Quebec CANADA Marketing Authorization Holder Pfizer Canada ULC 17300 Trans-Canada Highway Kirkland H9J 2M5 Quebec CANADA B. Champix 0.5 / 1.0 mg tablet kit DIN, NPN, DIN-HIM DIN 02298309 Dosage form Kit Strength Varenicline tartrate 0.5 mg Varenicline tartrate 1.0 mg Lot or serial number 00019062, 00020452, 00020451 Companies Recalling Firm Pfizer Canada ULC 17300 Trans-Canada Highway Kirkland H9J 2M5 Quebec CANADA Marketing Authorization Holder Pfizer Canada ULC 17300 Trans-Canada Highway Kirkland H9J 2M5 Quebec CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...